The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders.
Real name Litzy Lara Banuelos, Emily Willis is 'permanently disabled' after her brain was starved of oxygen for a prolonged ...
The 25-year-old is now semi-conscious in hospital, unable to move or speak, and can only track things with her eyes ...
The 26-year-old, whose real name is Litzy Lara Banuelos, entered the rehab center for her addiction to the dissociative anesthetic drug, which she was taking 5 to 6 grams of per day, her family ...
Once ketamine addiction consumed her ... Emily can now follow things with her eyes. However, she can’t speak or move. In 2018 ...
A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.
WALLINGFORD, Conn. (WTNH) — A new facility opened in Wallingford Saturday afternoon that treats mental health conditions with low doses of Ketamine. Centerpiece Behavioral Health Services and ...
If your eyes bulge more than is typical, it could be a serious health condition like hyperthyroidism. It’s important to share your symptoms and medical history with your doctor. Depending on the ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
The ketamine-derived drug was first approved in 2019 to be used in combination with antidepressants, and later for patients experiencing suicidal thoughts or actions. “Now that it is also ...
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
Spravato, which is derived from ketamine, is not a new drug—it first came on the market in 2019. The spray was previously approved as a companion treatment to an oral antidepressant, as well as ...